DC therapy? Let the natural killer answer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and tumor escape.

Original languageEnglish (US)
Pages (from-to)1892
Number of pages1
JournalBlood
Volume106
Issue number6
DOIs
StatePublished - Sep 15 2005
Externally publishedYes

Fingerprint

Natural Cytotoxicity Triggering Receptor 3
Tumor Escape
T-cells
Cytotoxicity
Natural Killer Cells
Dendritic Cells
Tumors
T-Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

DC therapy? Let the natural killer answer. / Farag, Sherif.

In: Blood, Vol. 106, No. 6, 15.09.2005, p. 1892.

Research output: Contribution to journalArticle

Farag, Sherif. / DC therapy? Let the natural killer answer. In: Blood. 2005 ; Vol. 106, No. 6. pp. 1892.
@article{bfc336c0d4bd45458f3f2dadec77f30f,
title = "DC therapy? Let the natural killer answer",
abstract = "Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and tumor escape.",
author = "Sherif Farag",
year = "2005",
month = "9",
day = "15",
doi = "10.1182/blood-2005-06-2608",
language = "English (US)",
volume = "106",
pages = "1892",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - DC therapy? Let the natural killer answer

AU - Farag, Sherif

PY - 2005/9/15

Y1 - 2005/9/15

N2 - Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and tumor escape.

AB - Natural killer cells from the majority of AML patients show defective killing of immature dendritic cells due to low expression of the natural cytotoxicity receptor NKp30. Defective killing of immature DCs leads to the emergence of tolerogenic T cells and tumor escape.

UR - http://www.scopus.com/inward/record.url?scp=24744460758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744460758&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-06-2608

DO - 10.1182/blood-2005-06-2608

M3 - Article

VL - 106

SP - 1892

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -